|
ZNF823 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73840000172731E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69039999997622E-07 |
| Normal-vs-Stage2 |
4.50689999997866E-06 |
| Normal-vs-Stage3 |
2.92320001538116E-09 |
| Normal-vs-Stage4 |
4.3017001072343E-10 |
| Stage1-vs-Stage2 |
8.202600E-01 |
| Stage1-vs-Stage3 |
4.230100E-02 |
| Stage1-vs-Stage4 |
4.361700E-03 |
| Stage2-vs-Stage3 |
2.473800E-01 |
| Stage2-vs-Stage4 |
8.716300E-02 |
| Stage3-vs-Stage4 |
4.144200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.50060000483998E-08 |
| Normal-vs-AfricanAmerican |
3.2827000007174E-08 |
| Normal-vs-Asian |
4.955500E-04 |
| Caucasian-vs-AfricanAmerican |
1.390240E-01 |
| Caucasian-vs-Asian |
8.086200E-02 |
| AfricanAmerican-vs-Asian |
3.238300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.08489999948314E-07 |
| Normal-vs-Female |
7.14129999579427E-09 |
| Male-vs-Female |
7.469900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.51530000050515E-07 |
| Normal-vs-Age(41-60Yrs) |
1.75250000067351E-08 |
| Normal-vs-Age(61-80Yrs) |
5.73439995488201E-09 |
| Normal-vs-Age(81-100Yrs) |
3.747900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.816800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.921900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.250000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.758800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.651600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.178600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.710400E-02 |
| Classical-VS-Follicular |
9.788400E-02 |
| Classical-VS-Other |
9.504600E-01 |
| Classical-VS-Normal |
3.90219999979458E-07 |
| Tall-VS-Follicular |
4.518000E-01 |
| Tall-VS-Other |
3.134800E-01 |
| Tall-VS-Normal |
2.264300003052E-08 |
| Follicular-VS-Other |
5.974000E-01 |
| Follicular-VS-Normal |
5.69570000052977E-08 |
| Other-VS-Normal |
4.400100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.69440000205879E-08 |
| Normal-vs-N1 |
9.39719999593081E-08 |
| N0-vs-N1 |
5.932400E-01 |
|
|
